CURIS INC

Analysis for Ticker: CRIS

Curis Inc is a biotechnology firm supposedly fighting cancer by developing a drug called emavusertib for patients with leukemia. The reality is a mathematical nightmare where the company has piled up an accumulated deficit of 1,2$ billion while its bank account has dwindled to almost nothing. It is like one person who owes one million dollars but only has five dollars in their pocket and keeps trying to buy things with a credit card that has a 100% interest rate. The business is not medicine; it is an accounting illusion designed to hide that they have already sold off their only money-making asset just to keep their name on a computer screen at the stock exchange.